Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Morgan Stanley raised Honeywell Aerospace (HONA) to Overweight with a $205 price target, highlighting a substantial valuation discount to peers. The call rests on the view that supply-chain issues are solvable and that a 2027-2028 recovery will close the gap. Counterarguments include negative book equity, multiple downward earnings revisions, and c…
Array Technologies is at an inflection: a new 60-degree DuraTrack variant and solid free cash flow position give the company room to win larger, weather-hardened utility projects in 2027. At a sub-$800M market cap and FCF of $134.7M, the risk/reward looks favorable for a long trade into mid-2027, provided developers lean into hail-resistant tracker…
WTI (West Texas Intermediate) and Brent are the two dominant crude benchmarks, trading at $85.10 and $92.23 respectively, leaving a $7.13 spread that reflects geography, supply risk and market structure. For newcomers, WTI typically offers clearer news linkage, deeper liquidity and lower apparent geopolitical sensitivity; Brent is the more global g…
K Wave Media Ltd., a Nasdaq-listed company specializing in AI infrastructure and related technologies, has entered into a definitive agreement for a registered direct offering of 526,314 ordinary shares at $1.90 per share, raising approximately $1 million in gross proceeds. The offering is expected to close around August 20, 2026, subject to custom…
Regeneron Pharmaceuticals announced FDA approval of Pasatru™ (garetosmab-grts) for adults with FOP, a rare genetic disorder causing abnormal bone growth. In the positive Phase 3 OPTIMA trial, Pasatru significantly reduced new heterotopic ossification lesions by over 90% and decreased clinician-assessed flare-ups compared to placebo, providing a tra…
Moderna shares vaulted 142.74% to $152.83 intraday after a Phase 3 readout for its personalized mRNA cancer vaccine, triggering a large short squeeze against 13.5% short interest. While the clinical result marks a first for mRNA oncology and underpins a substantive re-rating, technical indicators and valuation gaps raise significant mean-reversion …
Marvell's stock is pricing in a transformational customer win. Valuation still looks rich on traditional metrics, but immediate revenue and scale levers — plus a clean balance sheet and bullish technicals — create a favorable risk/reward for a mid-term swing trade. Entry, stop and targets provided.
Enbridge (ENB) offers a 5.4%+ yield, a CA$41 billion secured capital backlog through 2033 and a cash-flow profile that's largely protected by regulated and contract-backed businesses. The stock is trading below several moving averages with RSI ~30, presenting a mid-term buying opportunity. This trade idea lays out an actionable entry, stop and targ…
Tesla shares are down materially from last year's highs, but several underappreciated operational developments and compressed expectations create a defined-risk entry. This trade targets a rebound into the low $400s over the next 45 trading days, with a stop below key technical support and clear exit criteria if robotaxi delays or margin deteriorat…
Analog Devices reported record fiscal Q3 2026 results with revenue of $4.02 billion and EPS of $3.45, both ahead of consensus. Management guided to an even stronger Q4 and outlined multi-quarter drivers, including accelerating data center demand, an Empower acquisition set to begin contributing in FY2027, and sustained strength in industrial and au…
Carl Zeiss Meditec (CZMWY) has bounced off its March low and technicals now show sustained bullish momentum. With a $3.36B market cap, improving moving averages, and tailwinds in ophthalmics and advanced optics, this trade aims to capture a re-acceleration over the next 45 trading days. Entry, stop and target are defined with a clearly articulated …
Chemung Financial Corporation announced a 5.9% increase in its quarterly dividend to $0.36 per share, marking a total dividend rise of 16.1% since 2025. This move demonstrates the company’s robust financial position and ongoing commitment to returning value to shareholders. The dividend will be payable on October 1, 2026, to shareholders of record …
AMD's Helios platform rollout and accelerating data-center demand are translating into rapid earnings leverage. With revenue up roughly 50% year-over-year in the last quarter and free cash flow of $8.4B, the company can sustain R&D and capacity growth. Valuation is rich on headline P/E, but execution and margin expansion should drive EPS growth tha…
Lyntris Inc. raised $297.5 million in a reduced initial public offering but its shares opened below the offering price, falling about 11% in their first day of trading. The Falls Church, Virginia-based sensor company priced 17 million shares at $17.50 each and opened on the NYSE at $15.50, giving it a market value of $1.68 billion based on outstand…
Canadian and U.S. trade officials met in Ottawa after U.S. President Donald Trump temporarily paused planned 50% tariffs on some Canadian products for three days. Negotiators are working against a new deadline of 12:01 a.m. ET on Saturday when tariffs on $20 billion of Canadian goods would take effect if no agreement is reached. Auto tariffs, rules…
Merck rallied more than 14% today following reports of a positive cancer vaccine readout in collaboration with Moderna. The move leaves the stock extended but supported by strong free cash flow ($16.06B), a $369B market cap and an attractive dividend yield (~2.49%). We outline a mid-term trade plan to buy a breakout, set a protective stop, and targ…
President Donald Trump told reporters he intends to meet North Korean leader Kim Jong Un and stated that North Korea possesses 57 "very powerful" nuclear weapons. His comments followed an order to Pentagon officials to cut short joint military exercises with South Korea and came during remarks at a White House helipad construction site. Estimates o…
The US Commodity Futures Trading Commission has imposed trading and registration prohibitions on two former FTX executives but opted not to seek monetary penalties, citing their cooperation. The settlement, filed in federal court in Manhattan, ties back to the 2022 collapse of FTX and follows guilty pleas and testimony against Sam Bankman-Fried.
Monarch Casino & Resort, Inc. announced that Spa Monarch has been named the No.1 Best Hotel Spa in the Nation in the 2026 USA TODAY 10Best Readers' Choice Awards. This recognition is a testament to the resort's commitment to exceptional guest experiences, supported by the spa's extensive amenities and personalized treatment options. The accolade bu…
Germany's main equity gauges ended Wednesday with small net gains as advances in software, chemicals and food & beverages helped offset losses in semiconductor and defense names. The DAX finished up 0.01%, with the MDAX and TecDAX also in positive territory. Market breadth was narrowly positive and volatility, as measured by the DAX volatility …
Paris-listed shares closed marginally lower Wednesday as sector losses in Financials, Utilities and Industrials offset gains in several large-cap names. The CAC 40 fell 0.09% while the broader SBF 120 declined 0.07%. Commodity markets were firmer, with gold and crude futures posting notable advances.
Rocket Lab's recent $397 million Space Force award changes the investment calculus. The deal, plus a $2.36 billion backlog and visible path to larger, recurring government work, reduces execution risk on top-line visibility while Neutron remains the key operational trigger. Valuation is still demanding, so this is a tactical long with defined stops…
Meta's shares are trading near the recent low after litigation headlines. The company still generates strong free cash flow ($40.98B), posts healthy returns (ROE ~26%), and trades at a ~20x P/E and ~13x EV/EBITDA. This trade idea outlines a mid-term long with a clear entry, stop, and target, while laying out the catalysts and risks that matter.
PMGC Holdings Inc. disclosed a 1-for-10 reverse stock split of its common stock effective August 21, 2026, reducing the number of shares outstanding while proportionally increasing the share price. The company's ticker symbol ELAB remains unchanged but with a new CUSIP. The reverse split adjusts stock awards, options, and warrants accordingly witho…
Jade Biosciences (JBIO) just delivered interim Phase 1 data suggesting an every-12-week dosing profile for JADE101 with ~70% IgA reductions. With $336M in cash, a recent $150M offering, and a market cap of roughly $1.44B, the stock offers a mid/long-term asymmetric payoff: buy near $22.71 with a stop at $18.50 and a pragmatic target of $34.00 over …
